Table 2.

Univariate and multivariate analyses of prognostic factors for survival among patients with GC.

	Univariable analysis		Multivariable analysis
	HR (95%CI)	P	HR (95%CI)	P
Age (≥65 vs. < 65)	1.0925 (1.04–3.564)	0.087
Sex (male vs. female)	1.193 (0.654–2.207)	0.574
Tumor location (antrum vs. other parts)	0.617 (0.368–1.033)	0.066
Tumor size (≥5cm vs. < 5cm)	4.301 (2.331–7.937)	0.000	2.822 (1.362–5.848)	0.005
Distant metastasis (Yes or No)	2.454 (1.045–5.761)	0.039	1.408 (0.575–3.449)	0.454
Lymph node metastasis (Yes or No)	2.778 (1.403–5.50)	0.003	1.461 (0.627–3.407)	0.380
TNM stage (I/II vs. III/IV)	2.975 (1.699–5.211)	0.023	1.206 (0.552–2.634)	0.639
T stage (T1/T2 vs. T3/T4)	1.856 (1.031–3.341)	0.039	0.757 (0.385–1.487)	0.419
GLI1 (high vs. low)	4.153 (2.382–7.242)	0.000	2.209 (1.067–3.857)	0.031
RAB31 (high vs. low)	5.965 (3.224–11.038)	0.000	3.67 (1.893–7.144)	0.000

P value was italicized when P < 0.05. HR, Hazard ratio; CI, Confidence interval.